Skip to main
NGVT
NGVT logo

Ingevity (NGVT) Stock Forecast & Price Target

Ingevity (NGVT) Analyst Ratings

Based on 2 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Ingevity Corp has strategically executed an asset sale aimed at refining its portfolio, which is expected to enhance operational focus and reduce earnings volatility. This initiative is anticipated to improve the margin profile of the business, contributing positively to the company's overall financial stability. Furthermore, the company's performance outlook remains optimistic, as management sees potential for upside in financial targets through continued execution of its strategic initiatives.

Bears say

Ingevity Corp faces significant financial risks that could negatively impact its stock performance, particularly if there is a decline in global auto production, which could hinder its transition to alternative fuels and result in a dip in earnings. Additionally, the potential for margins to remain constrained in the 4-5% range raises concerns about the valuation multiples being considerably higher than prior expectations, suggesting inflated projections. Furthermore, various external risks, including potential patent cliffs, automotive tariffs affecting the Performance Materials segment, and competitive pressures, further complicate the company's financial outlook.

Ingevity (NGVT) has been analyzed by 2 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ingevity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ingevity (NGVT) Forecast

Analysts have given Ingevity (NGVT) a Hold based on their latest research and market trends.

According to 2 analysts, Ingevity (NGVT) has a Hold consensus rating as of Dec 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $62.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $62.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ingevity (NGVT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.